MP
Mehul Pravin Shah
About Mehul Pravin Shah
Data last updated:
Mehul Pravin Shah is a Director at Precise Biopharma Private Limited (since 2005), Director at Precise Chemipharma P Ltd (since 2024) and Director at Blisson Mediplus Private Limited (since 2013), and holds 8 more current directorships. The companies operate in Pharma, Healthcare and Travel and Hospitality. The 6 current companies with reported revenue have a combined latest revenue of ₹346 Cr; the largest is Precise Biopharma Private Limited at ₹201 Cr (FY 2025). Earlier, Mehul Pravin Shah was a Designated Partner at Embrion Art Surat Llp (2017–2024) and Director at Bioaltus Pharmaceuticals Private Limited (2021–2022) and 6 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Apr 2005 | 2005 | ₹201 Cr (FY 2025) | Active | |
| Director | 01 Jun 2024 | 1993 | ₹48.20 Cr (FY 2025) | Active | |
| Director | 10 Jun 2013 | 2013 | ₹44.12 Cr (FY 2024) | Active | |
| Director | 09 May 2019 | 2019 | ₹43.99 Cr (FY 2024) | Active | |
| Director | 02 Aug 2021 | 2021 | ₹8.41 Cr (FY 2024) | Active | |
| Director | 16 Jan 2014 | 2011 | ₹19.4 Lakh (FY 2025) | Active | |
| Designated Partner | 10 Nov 2025 | 2025 | Active | ||
| Designated Partner | 06 Aug 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 05 Jun 2017 | 2017 | Active | ||
| Director | 15 Jan 2021 | 2014 | ₹118 Cr (FY 2025) | Active | |
| Director | 16 Feb 2016 | 2016 | ₹94 Lakh (FY 2025) | Active | |
| Director | 11 Jan 2013 | 2013 | Strike Off | ||
| Director | 07 Apr 2017 | 2017 | ₹45.4 Lakh (FY 2025) | Active | |
| Director | 10 May 2011 | 2011 | Active | ||
| Director | 17 Oct 2012 | 2012 | Strike Off | ||
| Director | 08 Jan 2013 | 2013 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Mehul Pravin Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rachana Mehul Shah | 09616935 | Precise Biopharma Private Limited , Cyrus Remedies Private Limited and 2 more | Additional Director |
| Sunil Sadanand Sukhathankar | 03148373 | Precise Biopharma Private Limited , Solasta Laboratories Private Limited | Director |
| Gauri Pranay Shah | 10344885 | Precise Chemipharma P Ltd | Director |
| Pranay Pravin Shah | 02657734 | Precise Chemipharma P Ltd , Suremed Lifecare Private Limited | Director |
| Subhendu Chattopadhyay | 08639747 | Blisson Mediplus Private Limited | Director |
| Tushar Madhukar Patil | 08639934 | Blisson Mediplus Private Limited , Blisson Medica Private Limited and 2 more | Director |
| Shripad Joshi | 08639827 | Blisson Medica Private Limited | Director |
| Navin Manji Patel | 01317855 | Suremed Lifecare Private Limited | Director |
| Pravin Vrajlal Shah | 01678880 | Suremed Lifecare Private Limited | Director |
| Jayant Jagannath Khandare | 06585502 | Canvin Innovation Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mehul Pravin Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mehul Pravin Shah
Mehul Pravin Shah currently holds 11 directorships: Precise Biopharma Private Limited (Director, since 06 Apr 2005, revenue ₹201 Cr (FY 2025)); Precise Chemipharma P Ltd (Director, since 01 Jun 2024, revenue ₹48.20 Cr (FY 2025)); Blisson Mediplus Private Limited (Director, since 10 Jun 2013, revenue ₹44.12 Cr (FY 2024)); Blisson Medica Private Limited (Director, since 09 May 2019, revenue ₹43.99 Cr (FY 2024)); Cyrus Remedies Private Limited (Director, since 02 Aug 2021, revenue ₹8.41 Cr (FY 2024)); and 6 more.
Mehul Pravin Shah was first appointed on 06 Apr 2005 as Director at Precise Biopharma Private Limited. The most recent appointment on record is 10 Nov 2025 at Bmedica One Llp.
The 6 current companies of Mehul Pravin Shah that report revenue have a combined latest revenue of ₹346 Cr: Precise Biopharma Private Limited ₹201 Cr (FY 2025); Precise Chemipharma P Ltd ₹48.20 Cr (FY 2025); Blisson Mediplus Private Limited ₹44.12 Cr (FY 2024); Blisson Medica Private Limited ₹43.99 Cr (FY 2024); Cyrus Remedies Private Limited ₹8.41 Cr (FY 2024); and 1 more.
Mehul Pravin Shah held 8 earlier board appointments: Embrion Art Surat Llp (Designated Partner, 05 Jun 2017 to 19 Apr 2024); Bioaltus Pharmaceuticals Private Limited (Director, 15 Jan 2021 to 25 Aug 2022); Stembrella Precise Healthcare Private Limited (Director, 16 Feb 2016 to 04 Nov 2019); Priserve Infratech Limited (Director, 11 Jan 2013 to 28 Mar 2018); Embrion Art Private Limited (Director, 07 Apr 2017 to 22 Mar 2022); and 3 more.
The current boards of Mehul Pravin Shah's companies include Rachana Mehul Shah (Precise Biopharma Private Limited), Sunil Sadanand Sukhathankar (Precise Biopharma Private Limited), Gauri Pranay Shah (Precise Chemipharma P Ltd), Pranay Pravin Shah (Precise Chemipharma P Ltd), Subhendu Chattopadhyay (Blisson Mediplus Private Limited), Tushar Madhukar Patil (Blisson Mediplus Private Limited), among others.